Real-World Study of IL-23 Inhibitors in Active Crohn's Disease
NCT07545317 is an observational study sponsored by Sixth Affiliated Hospital, Sun Yat-sen University. As of 18 Nov 2026, it is recruiting participants. It studies IL-23 inhibitor and TNF inhibitors in Crohn's Disease. The registry lists an enrollment of 665 participants at 1 site in 1 country. The registry lists a start date of 16 Apr 2026 and a primary completion date of 31 Aug 2027. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT07545317 |
| Status | Recruiting |
| Study type | Observational study |
| Lead sponsor | Sixth Affiliated Hospital, Sun Yat-sen University |
| Enrollment | 665 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Crohn's Disease |
| Drugs | IL-23 inhibitor and TNF inhibitors |
| Start | 16 Apr 2026 |
| Primary completion | 31 Aug 2027 |
| Study completion | 31 Aug 2028 |
| Last update posted | 9 Jul 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Sixth Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong
Recruiting
Sites by country
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT07545317
Each answer restates registry values shown on this page.
What is NCT07545317?
NCT07545317 is an observational study sponsored by Sixth Affiliated Hospital, Sun Yat-sen University. It studies IL-23 inhibitor and TNF inhibitors in Crohn's Disease.
Is NCT07545317 recruiting?
As of 18 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.
Who leads NCT07545317?
The registry names Wei Wang, MD (principal investigator, Sixth Affiliated Hospital, Sun Yat-sen University) as the overall official.
Where does NCT07545317 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: China.
Which drugs does NCT07545317 study?
The registered drug and biological interventions are IL-23 inhibitor and TNF inhibitors.
When is NCT07545317 expected to complete?
The registry lists a primary completion date of 31 Aug 2027 and a study completion date of 31 Aug 2028. The sponsor last updated the record on 9 Jul 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.